Company News

Since our establishment in 1997, Tianlong has been dedicated to revolutionizing molecular diagnostics through our PCR solutions. Our commitment to excellence has been recognized with the prestigious national S&T Progress Award in 2021, showcasing our continuous efforts in advancing the field. Along the way, we have achieved significant milestones, including strategic investments and the establishment of subsidiary companies. These accomplishments have solidified our position as a pioneer in class III medical device manufacturing in China.

Tianlong's Business Coverage Map: Global Partnerships and Leadership

At Tianlong, we believe in the power of collaboration and global partnerships. Our strategic collaborations with enterprises worldwide have strengthened our position as a leader in professional diagnostic products. By joining forces with key players in the industry, we ensure that our customers have access to the most advanced and innovative PCR solutions available. With a strong presence in key markets and regions, we continue to expand our business coverage, delivering our cutting-edge products and services to customers around the globe.

The Power of Tianlong's R&D Team: Fueling Innovation and Breakthroughs

At the heart of our success lies our exceptional R&D team. Comprised of experts in genetics, optics, software, and various other fields, our team is driven by a passion for innovation. Through collaboration with renowned institutions, such as the University of Utah and Oxford University Hospital, we continuously advance our technological capabilities. This collaboration ensures that our PCR solutions remain at the forefront of molecular diagnostics, enabling our customers to achieve accurate and reliable results.

Our commitment to innovation has been recognized through various technical innovations and awards. Overcoming critical challenges in nucleic acid testing, we have developed groundbreaking technologies that have revolutionized the field. These advancements include addressing cross-contamination during nucleic acid extraction, improving temperature uniformity for gene amplification, and introducing automated high-throughput multiplexed nucleic acid detection and quantification. Through these innovations, we provide our customers with state-of-the-art PCR solutions that enhance their molecular diagnostics capabilities.

Conclusion

In conclusion, Tianlong PCR Solutions is committed to empowering molecular diagnostics through our innovative and reliable products. With a rich history of success, global partnerships, and a dedicated R&D team, we continue to lead the industry in providing cutting-edge PCR solutions. Our commitment to excellence and continuous innovation ensures that our customers have access to the most advanced molecular diagnostic tools available, enabling them to make meaningful contributions to healthcare and scientific research. Experience the power of Tianlong PCR Solutions and unlock the full potential of molecular diagnostics.